Total Payments
$35,823
2024 Payments
$23.72
Companies
18
Transactions
79
Medicare Patients
2,129
Medicare Billing
$378,180
Payment Breakdown by Category
Other$31,535 (88.0%)
Consulting$2,220 (6.2%)
Travel$1,059 (3.0%)
Food & Beverage$964.00 (2.7%)
Education$44.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,335 | 25 | 87.5% |
| Consulting Fee | $2,220 | 1 | 6.2% |
| Travel and Lodging | $1,059 | 1 | 3.0% |
| Food and Beverage | $964.00 | 48 | 2.7% |
| Honoraria | $200.00 | 1 | 0.6% |
| Education | $44.31 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $28,099 | 26 | $0 (2022) |
| PFIZER INC. | $4,684 | 13 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,247 | 3 | $0 (2022) |
| Daiichi Sankyo Inc. | $200.00 | 1 | $0 (2023) |
| Amgen Inc. | $99.32 | 5 | $0 (2020) |
| Genentech USA, Inc. | $92.99 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $91.41 | 5 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $85.09 | 7 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $45.71 | 3 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $29.66 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.72 | 1 | Genentech USA, Inc. ($23.72) |
| 2023 | $200.00 | 1 | Daiichi Sankyo Inc. ($200.00) |
| 2022 | $14,034 | 11 | Lilly USA, LLC ($11,674) |
| 2021 | $15,008 | 15 | Lilly USA, LLC ($10,575) |
| 2020 | $6,054 | 17 | Lilly USA, LLC ($5,850) |
| 2019 | $280.92 | 19 | PFIZER INC. ($70.08) |
| 2018 | $115.24 | 8 | PFIZER INC. ($57.72) |
| 2017 | $107.04 | 7 | Merck Sharp & Dohme Corporation ($36.18) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: BioOncology | ||||||
| 07/21/2023 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $200.00 | General |
| 12/22/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 12/07/2022 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $118.76 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 09/26/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Oncology | ||||||
| 09/20/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $20.99 | General |
| Category: Hematology | ||||||
| 08/11/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 05/26/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 05/26/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Oncology | ||||||
| 05/24/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $1,059.35 | General |
| 05/24/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $114.66 | General |
| 04/01/2022 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Oncology | ||||||
| 12/02/2021 | ADC Therapeutics America, Inc. | — | Education | In-kind items and services | $11.40 | General |
| 11/12/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 11/04/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 11/01/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 10/28/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 09/01/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 08/31/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Oncology | ||||||
| 08/24/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 08/05/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Oncology | ||||||
| 07/21/2021 | Lilly USA, LLC | VERZENIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/23/2021 | PFIZER INC. | IBRANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,410.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 430 | 706 | $174,505 | $74,914 |
| 2022 | 9 | 505 | 872 | $203,095 | $90,317 |
| 2021 | 11 | 569 | 994 | $239,480 | $107,745 |
| 2020 | 12 | 625 | 1,132 | $270,520 | $105,203 |
Total Patients
2,129
Total Services
3,704
Medicare Billing
$378,180
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 323 | $91,975 | $42,657 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 167 | $35,180 | $14,343 | 40.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 58 | $15,580 | $5,695 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 76 | $12,970 | $4,638 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,080 | $4,460 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 54 | $7,720 | $3,120 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 369 | $101,475 | $50,171 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 180 | $36,900 | $16,071 | 43.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 112 | $19,040 | $6,210 | 32.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $14,040 | $5,515 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 87 | $12,180 | $4,895 | 40.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 36 | 36 | $7,020 | $2,772 | 39.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 28 | $5,600 | $2,249 | 40.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,680 | $1,828 | 39.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 12 | $2,160 | $606.86 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 162 | 482 | $132,550 | $64,514 | 48.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 173 | $35,465 | $14,936 | 42.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 115 | $19,550 | $6,515 | 33.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 35 | 35 | $13,650 | $6,028 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 61 | $8,540 | $3,719 | 43.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 32 | 33 | $6,435 | $2,650 | 41.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $6,240 | $2,548 | 40.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 29 | $5,800 | $2,382 | 41.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $4,770 | $1,838 | 38.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 17 | 18 | $3,960 | $1,740 | 43.9% |
About Ranju Gupta
Ranju Gupta is a Hematology & Oncology healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720170301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ranju Gupta has received a total of $35,823 in payments from pharmaceutical and medical device companies, with $23.72 received in 2024. These payments were reported across 79 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,335).
As a Medicare-enrolled provider, Gupta has provided services to 2,129 Medicare beneficiaries, totaling 3,704 services with total Medicare billing of $378,180. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Allentown, PA
- Active Since 09/29/2006
- Last Updated 11/19/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1720170301
Products in Payments
- VERZENIO (Drug) $26,925
- IBRANCE (Drug) $4,576
- KEYTRUDA (Biological) $74.33
- SUTENT (Drug) $57.34
- GAZYVA (Biological) $46.19
- PIQRAY (Drug) $40.48
- ADAKVEO (Biological) $36.62
- Kyprolis (Biological) $30.67
- Imbruvica (Drug) $29.66
- XGEVA (Biological) $29.56
- LIBTAYO (Drug) $24.79
- Halaven (Drug) $23.81
- Venclexta (Biological) $23.72
- XTANDI (Drug) $23.50
- KANJINTI (Biological) $21.38
- Pomalyst (Drug) $20.99
- Blincyto (Biological) $17.71
- Bavencio (Biological) $17.65
- Nerlynx (Drug) $16.11
- BRAFTOVI (Drug) $15.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Allentown
Usama Gergis, Md, MD
Hematology & Oncology — Payments: $1.2M
Hematology & Oncology $1.2M
Dr. Basil Ahmed, M.d, M.D
Hematology & Oncology — Payments: $20,659
Hematology & Oncology $20,659
Dr. Dan Popescu, M.d, M.D
Hematology & Oncology — Payments: $11,467
Hematology & Oncology $11,467
Dr. Mohammad Kazemi, M.d, M.D
Hematology & Oncology — Payments: $5,938
Hematology & Oncology $5,938
Tara Morrison, Md, MD
Hematology & Oncology — Payments: $5,415
Hematology & Oncology $5,415
Chun Siu, Do, DO
Hematology & Oncology — Payments: $3,115
Hematology & Oncology $3,115